Categories: India

BRIEF-Genomed Shareholders To Sell 47.14% Stake In Company To Diagnostyka At 33 Zlotys/Shr

Nov 18 (Reuters) – Genomed SA: * SHAREHOLDERS AGREE TO SELL 47.14% STAKE IN COMPANY TO DIAGNOSTYKA FOR 33 ZLOTYS PER SHARE Source text: Further company coverage: (Reporting by Gdansk Newsroom)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Mastertrust Launches mtAlgoZ to Enhance Digital Trading with Automated Strategy Building and Execution

Ludhiana (Punjab) [India], November 18: Master Trust Limited (MASTERTR, BSE: 511768), a diversified financial services…

51 seconds ago

Target heads into holiday season with brighter sales outlook

By Juveria Tabassum and Nicholas P. Brown NEW YORK, Nov 18 (Reuters) - Target reported…

3 minutes ago

Gamers enter Vice City as Grand Theft Auto VI begins global rollout

By Aditya Soni and Rosalba O'Brien Nov 19 (Reuters) - The wait is over. After…

6 minutes ago

REFILE-FTSE 100 slips as commodity-linked stocks weigh; UK inflation at one-year high

(Rewrites headline to include commodity-linked stocks) Nov 18 - Britain's large-cap FTSE 100 was set…

13 minutes ago

Nasdaq futures rise as Nvidia forecast eases AI concerns ahead of Anthropic pricing

By Utkarsh Hathi and Ragini Mathur Nov 18 (Reuters) - Futures tied to the tech-heavy…

14 minutes ago